Life Science Success

Send us a text Introduction of InvivoSciences: Ayla Annac, co-founder and CEO of InvivoSciences, discusses the company's focus on developing therapies for cardiovascular and cardiometabolic diseases through innovative precision medicine technology. Personal Motivation: Ayla’s passion for addressing cardiovascular diseases stems from the personal loss of her father to heart disease at a young age, which motivated her to pursue solutions in this medical field. Technological Innovation: InvivoSciences utilizes a proprietary platform named Cordia for drug discovery and to identify subpopulations that match specific drugs, enhancing the effectiveness and safety of medications. Challenges and Perseverance: Ayla highlights the financial and industry challenges in drug development, emphasizing the need for increased investment and collaboration within the sector to bring innovative treatments to market. Vision and Future Goals: Ayla's mission extends beyond her company to push for a broader adoption of precision medicine in cardiovascular treatment, aiming to develop effective drugs that can significantly reduce the impact of heart diseases globally.   00:00 Introduction to Life Science Success Podcast 00:48 Sponsor Message: D3 Digital Media Marketing 01:30 Guest Introduction: Ayla Anak, CEO of InvivoSciences 02:10 Ayla's Personal Journey and Motivation 07:43 Challenges and Innovations in Cardiovascular Drug Development 08:59 The Journey of InvivoSciences 14:06 The Importance of Precision Medicine 24:54 Overcoming Challenges and Building a Team 34:39 Leadership Advice and Personal Inspirations 42:25 Conclusion and Final Thoughts

Send us a textIn this episode of the Life Science Success Podcast episode featuring Markus Gershater, co-founder of Synthace, listeners can learn about the intersection of synthetic biology, AI, and automation in revolutionizing life sciences research and development. Here are the key points: Role of Synthetic Biology and AI in Life Sciences: Markus discusses how Synthace leverages synthetic biology and AI to automate and enhance laboratory experiments, focusing on improving the efficiency and effectiveness of research processes. Design of Experiments (DOE): The conversation highlights the application of DOE, a statistical method that allows simultaneous examination of multiple input factors to determine their effect on a desired output, which is critical in managing the complexity of biological systems. Impact of Automation in Research: Markus explains how automation integrated through Synthace can significantly speed up and increase the precision of biological experiments, reducing the time and cost associated with traditional methods. Challenges and Opportunities with New Technologies: The discussion also covers the challenges of adopting new technologies in traditional research settings, the potential of AI to transform discovery processes, and the importance of aligning innovations with actual lab workflows. Vision and Aspirations for the Future: Markus shares his optimistic view on the potential of advanced technologies to make substantial impacts on life sciences, expressing hope and excitement about future possibilities to understand and control biological complexity more effectively. This episode provides insights into how cutting-edge technologies are shaping the future of biotechnological research and emphasizes the importance of integrating new tools with current scientific practices to maximize their benefits.

Send us a textIn this episode of Life Science Success, my guest is William Hind. William, the founder of Alpharmaxim, is transforming how pharma companies communicate their value to healthcare providers. In this episode of Life Science Success, host Don interviews William Hind, founder of Alpharmaxim, about the importance of effective communication in the life sciences industry.   William shares his journey from working at MSD (Merck) to founding Alpharmaxim, emphasizing the need for storytelling and behavioral science in pharmaceutical communications. They discuss overcoming barriers in healthcare communication, the role of behavioral science, and the potential and challenges of AI in the pharmaceutical industry. Brought to you by D3 Digital Media Marketing, this episode delves deep into transforming pharma communication through scientific, validated methods.   00:00 Introduction to Life Science Success Podcast 00:39 Sponsor Message: D3 Digital Media Marketing 01:22 Guest Introduction: William Hind of Alpharmaxim 01:51 William Hind's Career Journey 05:47 Founding Alpharmaxim 07:12 The Importance of Storytelling in Pharma 12:27 Behavioral Science in Healthcare Communication 18:55 Challenges in Pharma Communication 24:14 Staying Updated in the Industry 34:25 Leadership and Personal Insights 42:50 Conclusion and Farewell

Send us a text Tushar Pandey is a distinguished expert in the Life Sciences industry, currently making significant strides at SimBioSys with his innovative approach to healthcare technology. His contributions have been pivotal in advancing medical solutions and improving patient outcomes.   In this episode of the Life Science Success Podcast, host Don interviews Tushar Pandey, CEO and Co-founder of SymBioSys, an innovative company reshaping precision cancer care. Tushar shares his intriguing journey from Uganda to the United States, his transition from engineering to healthcare, and the personal experiences that sparked his passion for precision medicine. The discussion highlights SymBioSys’ groundbreaking work in creating digital, cost-effective diagnostics to reduce uncertainty in cancer treatment. They explore the importance of addressing diversity in medical models, harnessing the power of AI, and solving challenges in drug development and patient care. Agendas like the company's comprehensive platform for early-stage breast cancer get a deep dive, showcasing how they bridge imaging, genomics, and patient-centered care for improved outcomes. This conversation is a rich mix of personal narrative, professional insights, and forward-thinking solutions in life sciences.     00:00 Introduction to Life Science Success Podcast 00:34 Sponsor Message from D3 Digital Media Marketing 01:25 Guest Introduction: Tushar Pandey 02:27 Tushar's Background and Journey 04:30 Early Career and Transition to Healthcare 06:01 Strata Decision Technology and Cost Optimization 07:57 Personal Impact of Cancer and Shift to Precision Medicine 08:54 Founding Symbiosis and Mission 11:04 Challenges and Innovations in Cancer Treatment 12:21 Symbiosis' Approach to Precision Medicine 14:04 Scientific and Emotional Theses 15:34 Digital Solutions and Global Scale 15:58 Breast Cancer Treatment and FDA Approval 18:05 Supporting Drug Developers and Dosing Regimens 19:30 Digital Orientation and Multi-Omics Data 20:24 Identifying Critical Data in Precision Medicine

Send us a textIn this episode of the Life Science Success Podcast we are joined by Stephanie Oestreich, Managing Director of the Myeloma Investment Fund, who has an extensive background in life sciences, leadership, and a unique perspective as a semi-professional violinist.   Stephanie shares her extensive background in life sciences and leadership, and discusses her passion for finding cures and treatments for devastating diseases like multiple myeloma. She provides insight into the innovative work of the Myeloma Investment Fund, their mission, and the process of fostering and investing in breakthrough therapies. Stephanie also touches on her teaching role at MIT and her unique perspective as a semi-professional violinist, drawing parallels between her musical and professional experiences.   00:00 Introduction to the Podcast 00:32 Sponsor Message: D3 Digital Media Marketing 01:21 Meet Stephanie Asterik 01:54 Stephanie's Journey in Life Sciences 03:48 The Complexity of Multiple Myeloma 04:51 Investing in Innovation 08:42 The Role of the Myeloma Investment Fund 11:03 Stephanie's Background and Leadership Lessons 15:02 The Art of Playing the Violin 18:33 Leadership Insights from Music 22:07 Final Thoughts and Reflections 27:55 Conclusion and Farewell  

Send us a textIn this episode of Life Science Success, host Don interviews Dr. Sam Clark, founder and CEO of Terran Biosciences. They talk about Dr. Clark's innovative approach to creating new neuropsychiatric therapeutics and how his personal experiences with mental illness inspired him to enter the biotech industry.   The episode also explores various breakthroughs at Terran, including their innovative work with prodrugs, anti-psychotics, and psychedelics, along with their unique, efficient team structure modeled after Silicon Valley tech companies. Additionally, they delve into the inspiration, challenges, and methodologies that drive Terran's mission to provide affordable and modern treatments for patients in need.     00:00 Introduction to Life Science Success Podcast 00:40 Sponsor Message from D3 Digital Media Marketing 01:21 Guest Introduction: Dr. Sam Clark 02:12 Dr. Clark's Journey into Biotech 04:15 Founding Terran Biosciences 07:13 Innovative Projects at Terran 13:00 Psychedelic Compounds and Patient Use 20:00 Overcoming Barriers in Drug Development 23:57 Leadership and Inspiration 31:09 Conclusion and Final Thoughts

Send us a textIn this episode of Life Science Success, host Don interviews Vance Lyon, an accomplished chemist with a four-decade career in the life sciences industry. Vance discusses his educational background, career journey, and key experiences.   The conversation also delves into the vital role of Davos Pharma in providing comprehensive services for biotech companies, including API production, formulation, and IND filings. Vance shares insights on leadership, his inspirations, and concerns, while reflecting on his contributions to significant pharmaceutical projects. Join us for an engaging discussion on life sciences, chemistry, and the intricacies of pharmaceutical development.     00:00 Introduction to Life Science Success Podcast 00:39 Sponsor Message: D3 Digital Media Marketing 01:22 Meet Vance Lyon: A Journey in Chemistry 02:27 Early Life and Education 07:22 Career Beginnings at Parish Chemical 11:08 Transition to Kemmerer Polytech 12:57 Joining Davos and Key Projects 16:06 Services Provided by Davos 27:34 Leadership and Personal Insights 35:52 Conclusion and Farewell

Send us a textIn this episode of the Life Science Success Podcast, host Don Davis, PhD, MBA, interviews Dr. William Chou of Passage Bio. Dr. Chou discusses his transition from a practicing physician to a leader in biotechnology, reflects on the profound patient relationships he misses, and shares insights into Passage Bio's work on gene therapy for neurodegenerative diseases like Frontotemporal Dementia (FTD). They delve into the progress of their Phase 1/2 clinical study, the urgency of developing treatments for genetic mutations, and the potential impact on patients and their families.   Learn about the most recent developments and how Passage Bio is working to give those suffering from these life-threatening conditions hope.   00:00 Welcome and Introduction 00:25 William's Journey into Life Sciences 01:30 The Emotional Impact of Leaving Clinical Practice 02:31 Overview of Passage Bio 02:52 Understanding Frontotemporal Dementia (FTD) 06:38 Current Progress and Future Prospects 10:04 The Urgency and Hope for FTD Treatments 11:37 Goals and Closing Remarks

Send us a textIn this episode of the Life Science Success Podcast, Don Davis PhD, MBA interviews Igor Fisch, founder of NewBiologix. Igor shares his journey from academia to entrepreneurship, highlighting his success with Selexis, a company he sold in 2017 that specialized in monoclonal antibodies. He discusses the challenges of gene therapy, specifically the high costs, and NewBiologix's innovative approach to making gene therapy more affordable. Igor also provides insights into the industry's future, emphasizing the significance of stable production platforms for viral particles. 00:00 Introduction and Welcome 00:15 Igor's Journey into Life Sciences 00:37 The Success of Selexis 00:56 Transition to Gene Therapy 03:32 Challenges in Gene Therapy 03:50 The Importance of Stable Platforms 05:11 The Role of Biotech Startups 05:57 Balancing Science and Business 06:51 Networking at BIO Conference 08:14 Future Vision for New Biologics 09:21 Conclusion and Farewell

Send us a text In this episode of the Life Science Success Podcast, Dean Petkanas, co-founder of Kannalife Sciences, is interviewed at the Bio International Convention in San Diego. Dean shares his journey from investment banking in the 80s to founding Kannalife Sciences in 2009. He discusses the company's focus on developing cannabinoid-based drugs, specifically targeting chemotherapy-induced peripheral neuropathy. The conversation covers the challenges and opportunities in cannabinoid drug development, the importance of targeting specific types of pain, and the current state and future prospects of Kannalife Sciences. Dean also highlights the significance of partnering and collaboration in advancing novel therapeutics.       00:00 Welcome to the Life Science Success Podcast 00:20 Dean's Journey into Life Sciences 01:04 The Evolution of Kannalife Sciences 02:18 Challenges and Opportunities in Cannabinoid-Based Drugs 03:06 Understanding Pain and Neuropathy 06:08 Investment Insights and Market Trends 07:40 Kannalife Sciences's Current Focus and Future Prospects 10:02 The Importance of Partnering at Bio 11:02 Closing Remarks and Future Meetings